Literature DB >> 21495181

Decentralization of CD4 testing in resource-limited settings: 7 years of experience in six African countries.

F Marinucci1, S Medina-Moreno, A D Paterniti, M Wattleworth, R R Redfield.   

Abstract

Improving access to CD4 testing in resource-limited settings can be achieved through both centralized and decentralized testing networks. Decentralized testing models are more suitable for countries where the HIV epidemic affects a large portion of rural populations. Timely access to accurate CD4 results is crucial at the primary level of the health system. For the past 7 years, the Institute of Human Virology of the University of Maryland School of Medicine has implemented a flexible and sustainable three-phase model: (1) site assessment and improvement, (2) appropriate technology selection with capacity building through practical training and laboratory mentoring, and (3) quality management system strengthening and monitoring, to support accessibility to reliable CD4 counting at the point of service. CD4 testing capacity was established in 122 of 229 (53%) laboratories supported in Nigeria, Uganda, Kenya, Zambia, Tanzania, and Rwanda. Among those in rural settings, 46% (69/151) had CD4 testing available at site level, with a functioning flow cytometer installed at 28% (8/29) and 50% (61/122) of level 1 and level 2 sites, respectively. To strengthen local capacity, a total of 1,152 laboratory technicians were trained through 188 training sessions provided both on-site and at central locations. The overall quality of CD4 total testing procedure was assessed at 76% (92/121) of the laboratories, with 25% (23/92), 34% (31/92), and 33% (30/92) of them reporting excellent, good, and satisfactory performance. Balancing country-specific factors with the location of the clinic, number of patients, and the expected workload, was crucial in adapting this flexible model for decentralizing CD4 testing. The close collaboration with local governments and private vendors was key to successfully expanding access to CD4 testing within the framework of HIV care and treatment programs and for the sustainability of medical laboratories in resource-limited settings.
Copyright © 2011 International Society for Advancement of Cytometry.

Entities:  

Mesh:

Year:  2011        PMID: 21495181     DOI: 10.1002/cyto.a.21064

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  11 in total

1.  Specimen Referral Network to Rapidly Scale-Up CD4 Testing: The Hub and Spoke Model for Haiti.

Authors:  Frantz Jean Louis; Anna Janick Osborne; Viala Jean Elias; Josiane Buteau; Jacques Boncy; Angela Elong; Amber Dismer; Vikram Sasi; Jean Wysler Domercant; Daniel Lauture; S Arunmozhi Balajee; Barbara J Marston
Journal:  J AIDS Clin Res       Date:  2015-06-26

2.  Impact of horizontal approach in vertical program: continuous quality improvement of malaria and tuberculosis diagnostic services at primary-level medical laboratories in the context of HIV care and treatment program in Ethiopia.

Authors:  Francesco Marinucci; Tsegahun Manyazewal; Antonio D Paterniti; Sandra Medina-Moreno; Matthew Wattleworth; Juliana Hagembe; Robert R Redfield
Journal:  Am J Trop Med Hyg       Date:  2013-01-16       Impact factor: 2.345

3.  Evaluation of PIMA™® point of care technology for CD4 T cell enumeration in Kenya.

Authors:  Matilu Mwau; Ferdinard Adungo; Silvia Kadima; Ephantus Njagi; Carolyne Kirwaye; Najma Salim Abubakr; Lucy Atsieno Okubi; Mary Waihenya; Judi Lusike; Jackson Hungu
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

4.  Prioritizing CD4 count monitoring in response to ART in resource-constrained settings: a retrospective application of prediction-based classification.

Authors:  Livio Azzoni; Andrea S Foulkes; Yan Liu; Xiaohong Li; Margaret Johnson; Collette Smith; Adeeba Bte Kamarulzaman; Julio Montaner; Karam Mounzer; Michael Saag; Pedro Cahn; Carina Cesar; Alejandro Krolewiecki; Ian Sanne; Luis J Montaner
Journal:  PLoS Med       Date:  2012-04-17       Impact factor: 11.069

5.  Using BD Vacutainer CD4 Stabilization Tubes for Absolute Cluster of Differentiation Type 4 Cell Count Measurement on BD FacsCount and Partec Cyflow Cytometers: A Method Comparison Study from Zimbabwe.

Authors:  Florian Vogt; Rafael Van den Bergh; Andrea Bernasconi; Buhlebenkosi Moyo; Liberty Havazvidi; Mathieu Bastard; Laurence Flevaud; Fabian Taziwa; Eliphas Makondo; Sekesai Mtapuri-Zinyowera
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

6.  Access to CD4 Testing for Rural HIV Patients: Findings from a Cohort Study in Zimbabwe.

Authors:  Florian Vogt; Katie Tayler-Smith; Andrea Bernasconi; Eliphas Makondo; Fabian Taziwa; Buhlebenkosi Moyo; Liberty Havazvidi; Srinath Satyanarayana; Marcel Manzi; Mohammed Khogali; Anthony Reid
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

7.  Multisite evaluation of point of care CD4 testing in Papua New Guinea.

Authors:  Malin Malagun; Gideon Nano; Caroline Chevallier; Ragagalo Opina; Gola Sawiya; Joseph Kivavia; Albina Kalinoe; Kathalina Nathaniel; Oscillah Kaminiel; John Millan; Andrea Carmone; Mary Dini; Theresa Palou; Kum Topma; Evelyn Lavu; Jessica Markby
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

8.  A clinical prediction score in addition to WHO criteria for anti-retroviral treatment failure in resource-limited settings--experience from Lesotho.

Authors:  Niklaus Daniel Labhardt; Thabo Lejone; Matse'liso Setoko; Matalenyane Poka; Jochen Ehmer; Karolin Pfeiffer; Patrice Zinga Kiuvu; Lutgarde Lynen
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

9.  Comparative effectiveness of congregation- versus clinic-based approach to prevention of mother-to-child HIV transmission: study protocol for a cluster randomized controlled trial.

Authors:  Echezona E Ezeanolue; Michael C Obiefune; Wei Yang; Stephen K Obaro; Chinenye O Ezeanolue; Gbenga G Ogedegbe
Journal:  Implement Sci       Date:  2013-06-08       Impact factor: 7.327

10.  CD4 criteria improves the sensitivity of a clinical algorithm developed to identify viral failure in HIV-positive patients on antiretroviral therapy.

Authors:  Denise H Evans; Matthew P Fox; Mhairi Maskew; Lynne McNamara; Patrick MacPhail; Christopher Mathews; Ian Sanne
Journal:  J Int AIDS Soc       Date:  2014-09-15       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.